Bioequivalence of the New Formulation of WAL 801 CL Dry Syrup Compared to the Conventional Formulation of WAL 801 CL Dry Syrup in Healthy Male Volunteers

NCT02260050 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: WAL 801 CL dry syrup new formulation
DRUG: WAL 801 CL dry syrup conventional formulation

Sponsor

Boehringer Ingelheim